Report: Dual eligibles to cost more than others in drug plan

Share this article:

Dual eligibles will cost more than other beneficiaries for prescription drug plans participating in the new drug benefit, according to data released last month.

The drug use and costs of this population "may be sharply higher than those of other Medicare beneficiaries," according to an issue brief. Mathematica Policy Research Inc. disclosed state-by-state data in its report released August 22.

Medicaid reimbursement for prescription drugs for disabled duals under 65 years old was $2,143 in 1999, nearly 50% higher than the average reimbursement for disabled duals age 65 and over. Dual eligibles who receive both Medicaid and Medicare coverage make up about 70% of nursing home residents.

The Mathematica issue brief is available at http://www.mathematica.org/.

Share this article:

More in News

Antipsychotics reduction goal is 25% by end of 2015, CMS and provider groups announce

Antipsychotics reduction goal is 25% by end of ...

Long-term care providers are being asked to reduce the use of antipsychotic medications among residents by 25% by the end of 2015, and 30% by the end of 2016. Providers ...

CDC issues new guidelines on pneumococcal vaccine, says LTC flu vaccination rates remain low

CDC issues new guidelines on pneumococcal vaccine, says ...

Long-term care workers continued to have low rates of flu vaccination last season, despite there being 92% vaccination coverage overall among physicians and nurses, the Centers for Disease Control and ...

AL operators accused of withholding $2M in unpaid overtime, minimum wages ...

Four California assisted living operators are facing eight felony charges related to wage theft, tax and insurance violations, according to local reports.